微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -8.68% | -364.17% | 84.15% | 67/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -54.78% | -237.11% | -356.5% | 67/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | -12% | -91.39% | -105.83% | 66/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | -5.83% | -118.35% | -211.76% | 65/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | -1.87% | -1084.21% | 88.49% | 64/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | -16.25% | 21.31% | -159.17% | 66/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | -6.27% | 41.29% | -134.83% | 66/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | -2.67% | 65.64% | -1505.26% | 64/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 0.19% | 110.22% | 100.92% | 62/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | -20.65% | 7.36% | -93.35% | 67/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | -10.68% | -2372.34% | -37.45% | 67/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | -7.77% | -1353.23% | -317.74% | 67/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | -1.86% | -373.53% | 91.66% | 65/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | -22.29% | -641.02% | -4842.55% | 65/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 0.47% | -88.67% | -24.19% | 63/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 0.62% | -83.98% | -8.82% | 62/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.68% | -70.18% | -83.5% | 59/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 4.12% | 635.06% | -0.72% | 45/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 4.15% | 56.6% | 7.24% | 47/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 3.87% | 1582.61% | 69.74% | 34/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 2.28% | 153.33% | 396.1% | 27/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | -0.77% | 42.54% | -129.06% | 59/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 2.65% | 0% | 1052.17% | 52/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 0.23% | 0% | -74.44% | 62/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 0.9% | 20% | 167.16% | 58/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | -1.34% | 69.75% | -150.57% | 61/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 2.65% | 29.27% | 1052.17% | 55/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 0.23% | -69.74% | -69.33% | 60/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 0.75% | 13.64% | 116.93% | 58/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | -4.43% | -1063.04% | -316.1% | 65/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 2.05% | -8.89% | 169.74% | 59/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 0.76% | -46.1% | 15.15% | 62/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 0.66% | -28.26% | 43.48% | 54/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 0.46% | -91.97% | -79.56% | 60/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 2.25% | -60.53% | 59.57% | 53/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 1.41% | -70.87% | 53.26% | 56/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 0.92% | -54% | -83.94% | 48/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 5.73% | -47.96% | 0.53% | 51/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 5.7% | -33.02% | 17.77% | 40/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 4.84% | -7.63% | 142% | 35/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 2% | 3.63% | -81.83% | 39/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |